Dusan Ruzic

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 14

Top Topics

Histone Deacetylase

Molecular Dynamics

Top Venues

Pharmaceuticals (Basel, Switzerland)

Journal of chemical information and modeling

This page only lists publications with an associated author ORCID identifier.

Publications

Nemanja Djokovic, Ana Đurić, Dusan Ruzic, Tatjana Srdic-Rajic, Katarina Nikolic
Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Milan Beljkas, Aleksandra Ilic, Alen Cebzan, Branko Radovic, Nemanja Djokovic, Dusan Ruzic, Katarina Nikolic, Slavica Oljacic
Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer. Pharmaceutics 15 (11) (2023)
Dusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, Juan Francisco Santibanez, Sheraz Gul, Milan Beljkas, Ana Đurić, Arasu Ganesan, Aleksandar Pavic, Tatjana Srdic-Rajic, Milos Petkovic, Katarina Nikolic
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. Pharmaceutics 14 (12) (2022)
Dusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, Juan Francisco Santibanez, Sheraz Gul, Milan Beljkas, Ana Đurić, Arasu Ganesan, Aleksandar Pavic, Tatjana Srdic-Rajic, Milos Petkovic, Katarina Nikolic
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. Pharmaceutics 14 (12) (2022)
Ipek Bulut, Adam Lee, Ceyda Acilan, Dusan Ruzic, Roman Belle, Akane Kawamura, Sheraz Gul, Katarina Nikolic, Arasu Ganesan, Ceyda Acilan
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells. Cancers 14 (23) (2022)
Dusan Ruzic, Nemanja Djokovic, Tatjana Srdić-Rajić, Cesar Echeverria, Katarina Nikolic, Juan Francisco Santibanez
Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention. Pharmaceutics 14 (1) (2022)
Nemanja Djokovic, Dusan Ruzic, Minna Rahnasto-Rilla, Tatjana Srdic-Rajic, Maija K Lahtela-Kakkonen, Katarina Nikolic
Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket Dynamics. Journal of chemical information and modeling 62 (10) (2022)
Dusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, Juan Francisco Santibanez, Sheraz Gul, Milan Beljkas, Ana Đurić, Arasu Ganesan, Aleksandar Pavic, Tatjana Srdic-Rajic, Milos Petkovic, Katarina Nikolic
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. Pharmaceutics 14 (12) (2022)
Ipek Bulut, Adam Lee, Ceyda Acilan, Dusan Ruzic, Roman Belle, Akane Kawamura, Sheraz Gul, Katarina Nikolic, Arasu Ganesan, Ceyda Acilan
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells. Cancers 14 (23) (2022)
Ipek Bulut, Adam Lee, Ceyda Acilan, Dusan Ruzic, Roman Belle, Akane Kawamura, Sheraz Gul, Katarina Nikolic, Arasu Ganesan, Ceyda Acilan
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells. Cancers 14 (23) (2022)
Corentin Bon, Magdalena Barbachowska, Nemanja Djokovic, Dusan Ruzic, Yang Si, Laura Soresinetti, Corinne Jallet, Ambre Tafit, Ludovic Halby, Katarina Nikolic, Paola Barbara Arimondo
Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studies. Future medicinal chemistry 14 (8) (2022)
Dusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, Juan Francisco Santibanez, Sheraz Gul, Milan Beljkas, Ana Đurić, Arasu Ganesan, Aleksandar Pavic, Tatjana Srdic-Rajic, Milos Petkovic, Katarina Nikolic
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. Pharmaceutics 14 (12) (2022)
Nemanja Djokovic, Dusan Ruzic, Teodora Djikic, Sandra Cvijic, Jelisaveta Ignjatovic, Svetlana Ibric, Katarina Baralic, Aleksandra Buha Djordjevic, Marijana Curcic, Danijela Djukic-Cosic, Katarina Nikolic
An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main Protease. Molecular informatics 40 (5) (2021)
Corentin Bon, Yang Si, Melanie Pernak, Magdalena Barbachowska, Eva Levi-Acobas, Veronique Cadet Daniel, Corinne Jallet, Dusan Ruzic, Nemanja Djokovic, Teodora Djikic-Stojsic, Katarina Nikolic, Ludovic Halby, Paola Barbara Arimondo
Synthesis and Biological Activity of a Cytostatic Inhibitor of MLLr Leukemia Targeting the DOT1L Protein. Molecules (Basel, Switzerland) 26 (17) (2021)